WP
CELG

Westend Partners’s Celgene Corp CELG Stock Holding History

Westend Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$860K Buy
+11,550
New +$809K 1.03% 33

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Westend Partners's CELG Position: Q3 2013 in Review

Westend Partners opened a new position in Celgene Corp (CELG) in Q3 2013: 11,550 shares worth $860K. The stake represents 1.03% of the portfolio and ranks #33 among its holdings.

909 funds tracked by Wall St. Rank hold CELG as of Q3 2013.

  • Westend Partners held 11,550 shares of Celgene Corp worth $860K as of Q3 2013.
  • Celgene Corp was a new Westend Partners position in Q3 2013.
  • Celgene Corp made up 1.03% of Westend Partners's portfolio in Q3 2013, its #33 holding.
  • 909 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2013.

Based on Westend Partners's 13F filing for Q3 2013, filed 13 Nov 2013.